COVID-19 and Clinical Trials: a CRO's…
OCT to Remain Fully Operational, Available…
A message from the CEO:
Amid escalating public concern, this is to let you know that we are here to help, and here to stay.
All employees of our company will continue to work with you without any interruption and can be reached by e-mail or telephone.
We have limited our travel for the foreseeable future until the situation bears little to no risk and travel restrictions are lifted. However, we have expanded our team’s abilities to engage remotely and look forward to connecting with you online until the situation is resolved.
As World Health Organizations continue their efforts to battle Covid-19, we here at OCT Clinical are doing our part to ensure the safety of our team and those around us. Having moved part of our operations to work remotely, we will continue to support our Sponsors and Partners, as our entire industry works to ensure the safety of participants, health care workers, and research teams, along with the integrity of the studies and their data.
Please remember that during these uncertain times OCT Clinical will continue to stand by you and we will commit ourselves fully to the projects you have entrusted us with, ready to help your study and manage emergency response throughout the COVID-19 outbreak.
From the entire OCT team, we hope you and your families stay strong and in good health. OCT Clinical is optimistic that together, our businesses will emerge more robust and healthier than ever.
Thank you for your cooperation!
President, OCT Clinical